| ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers E Tacconelli, F Mazzaferri, AM de Smet, D Bragantini, P Eggimann, ... Clinical microbiology and infection 25 (7), 807-817, 2019 | 199 | 2019 |
| Platelets promote thromboinflammation in SARS-CoV-2 pneumonia F Taus, G Salvagno, S Canè, C Fava, F Mazzaferri, E Carrara, V Petrova, ... Arteriosclerosis, thrombosis, and vascular biology 40 (12), 2975-2989, 2020 | 170 | 2020 |
| Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis MM Hellou, A Górska, F Mazzaferri, E Cremonini, E Gentilotti, P De Nardo, ... Clinical Microbiology and Infection 27 (3), 341-351, 2021 | 99 | 2021 |
| Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage P De Nardo, E Gentilotti, F Mazzaferri, E Cremonini, P Hansen, ... International Journal of Infectious Diseases 98, 494-500, 2020 | 79 | 2020 |
| Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study E Righi, M Mirandola, F Mazzaferri, G Dossi, E Razzaboni, A Zaffagnini, ... Journal of Infection 84 (4), 566-572, 2022 | 74 | 2022 |
| Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis E Gentilotti, P De Nardo, E Cremonini, A Górska, F Mazzaferri, ... Clinical Microbiology and Infection 28 (1), 13-22, 2022 | 57 | 2022 |
| Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections E Concia, D Bragantini, F Mazzaferri Journal of Chemotherapy 29 (sup1), 19-28, 2017 | 54 | 2017 |
| Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors? V Donisi, M Sibani, E Carrara, L Del Piccolo, M Rimondini, F Mazzaferri, ... Journal of Antimicrobial Chemotherapy 74 (10), 2844-2847, 2019 | 48 | 2019 |
| Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for Neisseria gonorrhoeae and Mycoplasma genitalium ST Sadiq, F Mazzaferri, M Unemo Sexually transmitted infections 93 (S4), S65-S68, 2017 | 46 | 2017 |
| Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort E Gentilotti, A Górska, A Tami, R Gusinow, M Mirandola, JR Baño, ... EClinicalMedicine 62, 2023 | 35 | 2023 |
| Cytomegalovirus-induced gastrointestinal bleeding and pancreatitis complicating severe COVID-19 pneumonia: a paradigmatic case G Marchi, A Vianello, E Crisafulli, A Maroccia, SF Crinò, S Pecori, ... Mediterranean journal of hematology and infectious diseases 12 (1), 2020 | 25 | 2020 |
| Nocardia infection over 5 years (2011-2015) in an Italian tertiary care hospital F Mazzaferri, M Cordioli, E Segato, I Adami, L Maccacaro, P Sette, ... New Microbiol 41 (2), 136-140, 2018 | 25 | 2018 |
| Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial M Trøseid, JR Arribas, L Assoumou, AR Holten, J Poissy, V Terzić, ... Critical care 27 (1), 9, 2023 | 24 | 2023 |
| Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern F Mazzaferri, M Mirandola, A Savoldi, P De Nardo, M Morra, M Tebon, ... Elife 11, e79639, 2022 | 20 | 2022 |
| Long-term patient-centred follow-up in a prospective cohort of patients with COVID-19 E Righi, M Mirandola, F Mazzaferri, E Razzaboni, A Zaffagnini, ... Infectious diseases and therapy 10 (3), 1579-1590, 2021 | 20 | 2021 |
| A review of vaccinations in adult patients with secondary immunodeficiency E Righi, T Gallo, AM Azzini, F Mazzaferri, M Cordioli, M Merighi, ... Infectious Diseases and Therapy 10, 637-661, 2021 | 20 | 2021 |
| Excessive vitamin B12 and poor outcome in COVID-19 pneumonia A Dalbeni, M Bevilacqua, I Teani, I Normelli, F Mazzaferri, G Chiarioni Nutrition, Metabolism and Cardiovascular Diseases 31 (3), 774-775, 2021 | 20 | 2021 |
| Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project MD Pezzani, F Mazzaferri, M Compri, L Galia, NT Mutters, G Kahlmeter, ... Journal of Antimicrobial Chemotherapy 75 (Supplement_2), ii2-ii19, 2020 | 20 | 2020 |
| White paper: bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET … M Sibani, F Mazzaferri, E Carrara, MD Pezzani, F Arieti, S Göpel, M Paul, ... Journal of Antimicrobial Chemotherapy 75 (Supplement_2), ii33-ii41, 2020 | 12 | 2020 |
| High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia P Minuz, G Mansueto, F Mazzaferri, C Fava, A Dalbeni, MC Ambrosetti, ... Clinical Microbiology and Infection 26 (11), 1572-1573, 2020 | 11 | 2020 |
Giuliana Lo CascioAzienda Ospedaliera Universitaria Integrata- Verona在 ospedaleuniverona.it 的电子邮件经过验证
Giuliana Lo CascioAzienda Ospedaliera Universitaria Integrata- Verona在 ospedaleuniverona.it 的电子邮件经过验证